TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

Janssen: Response to TB CAB letter

Janssen's response to TB CAB letter regarding pharmacokinetic studies, paediatric studies, and compassionate use of bedaquiline.

/

Download the letter from here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


News

By Janssen Pharmaceutical Companies of Johnson & Johnson

Published: June 12, 2012, 8:36 p.m.

Last updated: June 13, 2012, 10:22 a.m.

Tags: None

Print Share